Clinical trial
EURECA (EUropeanRElapseCAlprotectin) Study - Calprotectin as Prediction Marker of Relapse in Patients With Quiescent Ulcerative Colitis
NCT05168917 is registered in ClinicalTrials.gov with DiaSorin Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- EURECA (EUropeanRElapseCAlprotectin) Study - Calprotectin as Prediction Marker of Relapse in Patients With Quiescent Ulcerative Colitis
- Lead sponsor
- DiaSorin Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 2, 2017
- Completion date
- January 13, 2020
- Enrollment
- 225 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.